Free shipping on all orders over $ 500

Licogliflozin

Cat. No. M28119
Licogliflozin Structure
Synonym:

LIK066

Size Price Availability Quantity
10mg USD 450  USD450 In stock
25mg USD 900  USD900 In stock
50mg USD 1320  USD1320 In stock
100mg USD 2200  USD2200 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor.

Chemical Information
Molecular Weight 416.46
Formula C23H28O7
CAS Number 1291094-73-9
Form Solid
Solubility (25°C) DMSO 100 mg/mL (ultrasonic)
Water 2 mg/mL (ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Alaa Mohamed Zaki, et al. Diabetes Metab Syndr. Dose-dependent efficacy and safety of licogliflozin on obese adults: A systematic review and meta-analysis of randomized controlled trials

[2] Stephen A Harrison, et al. Nat Med. Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study

[3] Olivia Tysoe. Nat Rev Endocrinol. Licogliflozin effective in PCOS treatment

[4] Susanne Tan, et al. Diabetes Obes Metab. Licogliflozin versus placebo in women with polycystic ovary syndrome: A randomized, double-blind, phase 2 trial

[5] Harold E Bays, et al. Obesity (Silver Spring). Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults with Overweight or Obesity

Related SGLT Products
Tianagliflozin

Tianagliflozin is an SGLT2 inhibitor that may be used in studies related to type 2 diabetes.

JTT-662

JTT-662 is an SGLT1 inhibitor that can be used in studies related to type 2 diabetes.

JP-2266

JP-2266 is a dual SGLT1/2 inhibitor that can be used in studies related to diabetes.

Tofogliflozin

Tofogliflozin(CSG-452) is a potent and highly specific sodium/glucose cotransporter 2(SGLT2) inhibitor with Ki values of 2.9, 14.9, and 6.4 nM for human, rat, and mouse SGLT2.

Mizagliflozin

Mizagliflozin (DSP-3235 free base) is a potent, orally active and selective SGLT1 inhibitor, with a Ki of 27 nM for human SGLT1. Mizagliflozin displays 303-fold selectivity over SGLT2. Mizagliflozin is used as an antidiabetic agent that can modify postprandial blood glucose excursion. Mizagliflozin also exhibits potential in the amelioration of chronic constipation.

  Catalog
Abmole Inhibitor Catalog




Keywords: Licogliflozin, LIK066 supplier, SGLT, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.